载体化ULK1/2和VPS34抑制剂用于瘤学的组织选择性自抑制
Lorenzo Cianni1, Kathryn Jacobs2,3, Sergei Grintsevich1
1Laboratory of Medicinal Chemistry (UAMC), Department of Pharmaceutical Sciences, University of Antwerp, 2610 Wilrijk, Belgium.
Journal of medicinal chemistry
|January 26, 2026
概括
研究人员开发了针对瘤的新型自抑制剂,以选择性地阻止癌细胞生存机制. 这些化合物在癌症治疗中表现有前途,通过抑制瘤中的特异性自,同时节省健康组织.
科学领域:
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
- 癌症研究 癌症研究
背景情况:
- 自是一种关键的细胞过程,对生存和恒常状态至关重要.
- 瘤利用自为塑性,适应性和治疗耐药性,使其成为治疗目标.
- 选择性自抑制在瘤中是必不可少的,因为它在健康组织中起着至关重要的作用.
研究的目的:
- 设计和验证瘤向的自抑制剂.
- 在癌细胞中开发选择性抑制自启动因子 (ULK1/2和VPS34) 的化合物.
- 探索瘤学的新型治疗策略.
主要方法:
- 使用瘤向载体的自开始因子抑制剂 (ULK1/2和VPS34) 的设计.
- 使用低纳米级ULK1/2抑制基架与RGR序列向合.
- 通过体外,细胞内和体外临床前模型验证的化合物.
主要成果:
- 开发出有前途的瘤向自抑制剂.
- 在临床前模型中证明化合物的选择性活性.
- 展示了抑制剂在向瘤特异性自的有效性.
结论:
- 开发的化合物是瘤向自抑制剂的第一个例子.
- 这些抑制剂为组织特异调节自提供了一种新的方法.
- 在瘤学和其他需要自调节的领域存在潜在的应用.
相关概念视频
Eukaryotic Transcription Inhibitors
11.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
Autophagy
5.8K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.8K
Feedback Inhibition
57.1K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.1K
Enzyme Inhibition
91.9K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
91.9K
What is Natural Selection?
128.1K
Natural selection is an evolutionary process in which individuals with survival-promoting traits reproduce at higher rates. These favorable traits become more common within a population or species. Naturally selected traits initially arise via random genetic mutations. In order for selection to occur, there must be variation within a population, the trait controlling the variation must be heritable, and there must be an evolutionary advantage for variation in the trait.
128.1K
Inhibition of Cdk Activity
6.0K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K


